Sopharma Trading AD (SFT)

Currency in BGN
5.80
-0.05(-0.85%)
Closed·

SFT Financial Summary

Key Ratios

P/E Ratio3.96
Price/Book1.07
Debt / Equity160.94%
Return on Equity31.08%
Dividend Yield0.00%
EBITDA93.21M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of BGN (except for per share items)

Earnings

Latest Release
May 28, 2025
EPS / Forecast
0.69 / --
Revenue / Forecast
563.51M / --
EPS Revisions
Last 90 days

FAQ

What were Sopharma Trading AD's earnings for the latest quarter?

The Sopharma Trading AD EPS (TTM) is 1.48. Sopharma Trading AD reported sales of 562.74, net income of 23.75, and EPS of 0.69 for the latest quarter.

What was Sopharma Trading AD's net income for the latest quarter?

Sopharma Trading AD's net income for the latest quarter was 23.75.

How did Sopharma Trading AD's performance compare year-over-year in the latest quarter?

The company's revenue moved from 544.88 in the previous quarter to 562.74 in the latest quarter, and net income moved from 8.27 to 23.75 compared to the previous quarter.

What is Sopharma Trading AD's net profit margin on a TTM basis?

Sopharma Trading AD's trailing twelve months (TTM) net profit margin is 2.06%.

How does Sopharma Trading AD's debt to equity ratio compare to industry standards?

Sopharma Trading AD's total debt-to-equity ratio is 160.94%.

What is Sopharma Trading AD's return on investment on a TTM basis?

Sopharma Trading AD's trailing twelve months (TTM) return on investment (ROI) is 31.08%.

Did Sopharma Trading AD gain or lose cash last quarter?

In the latest quarter, Sopharma Trading AD's net change in cash was -3.52 million.

What were Sopharma Trading AD's total assets and liabilities in the latest quarter?

As of the latest quarter, Sopharma Trading AD reported total assets of 875.86 million and total liabilities of 552.34 million.

How has Sopharma Trading AD's total revenue grown this year?

Sopharma Trading AD's total revenue was 544.88 in the previous quarter and 562.74 in the latest quarter.

What is Sopharma Trading AD's gross margin on a TTM basis?

Sopharma Trading AD's trailing twelve months (TTM) gross margin is 13.33%.

What was Sopharma Trading AD's revenue per share for the latest quarter?

Sopharma Trading AD's revenue per share for the latest quarter was 6.96.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.